Company profile for Obsidian Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Obsidian is a volcanic glass that is used to make sharp and precise blades. Reflecting our namesake, our approach enables precise, patient-specific engineering of cell and gene therapies. Like the diversity of obsidian sources, we value the diversity and unique talents of our people. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partners...
Obsidian is a volcanic glass that is used to make sharp and precise blades. Reflecting our namesake, our approach enables precise, patient-specific engineering of cell and gene therapies. Like the diversity of obsidian sources, we value the diversity and unique talents of our people. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1030 Massachusetts Ave Cambridge, MA 02138
Telephone
Telephone
(781) 806-6245
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Product Expo West

Natural Product Expo West

Not Confirmed

envelop Contact Supplier

Natural Product Expo West

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-01-12/obsidian-therapeutics-appoints-julie-feder-as-chief-financial-officer

PHARMIWEB
12 Jan 2026

https://www.businesswire.com/news/home/20250602726563/en/Obsidian-Therapeutics-Announces-Positive-Clinical-Data-from-OBX-115-in-Patients-with-Advanced-Melanoma-in-Ongoing-Multicenter-Study-at-the-2025-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

BUSINESSWIRE
02 Jun 2025

https://www.businesswire.com/news/home/20250428233100/en/Obsidian-Therapeutics-to-Present-Preclinical-Data-Supporting-Novel-Application-of-cytoDRiVE-Platform-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting

BUSINESSWIRE
28 Apr 2025

https://www.businesswire.com/news/home/20250425392001/en/Obsidian-Therapeutics-Announces-Multiple-Presentations-at-the-American-Association-for-Cancer-Research-Annual-Meeting

BUSINESSWIRE
25 Apr 2025

https://www.businesswire.com/news/home/20250423449840/en/Obsidian-Therapeutics-to-Present-Clinical-Data-from-OBX-115-its-Engineered-TIL-Cell-Therapy-for-Patients-with-Advanced-Melanoma-in-Oral-Presentation-at-the-2025-ASCO-Annual-Meeting

BUSINESSWIRE
23 Apr 2025

https://www.businesswire.com/news/home/20250106565493/en

BUSINESSWIRE
06 Jan 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty